EP Patent
EP3978483A1 — Crystalline toluene solvate of (s)-afoxolaner
Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2022-04-06 · 4y expired
What this patent protects
The invention relates to a crystalline toluene solvate form of (S)-afoxolaner, to processes for its preparation, and to pesticidal or parasiticidal compositions comprising it.
USPTO Abstract
The invention relates to a crystalline toluene solvate form of (S)-afoxolaner, to processes for its preparation, and to pesticidal or parasiticidal compositions comprising it.
Drugs covered by this patent
- Xdemvy (LOTILANER) · Tarsus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.